Comprehensive, multidisciplinary care across hematology, oncology, autoimmune disease and advanced cellular therapies.
GOBROAD Medical Group brings together leading physicians across disciplines to treat the most complex hematology and oncology conditions. Our care integrates proven treatments with innovative cellular and genetic therapies, coordinated through a Multidisciplinary Care (MDC) model.
Expert diagnosis and treatment for diseases of the blood and blood-forming organs.
Comprehensive care for blood cancers including leukemia, lymphoma and multiple myeloma, using chemotherapy, immunotherapy and stem cell transplantation.
Treatment for aplastic anemia, myelodysplastic syndromes, autoimmune hemolytic anemia and paroxysmal nocturnal hemoglobinuria (PNH).
Management of thalassemia and other inherited blood disorders, including transfusion programs and curative stem cell transplant options.
Multidisciplinary treatment for cancers that arise in organs and tissues.
Stomach, esophageal, colorectal, pancreatic, gallbladder, cholangiocarcinoma and liver cancers — treated with surgery, targeted therapy and immunotherapy.
Lung cancer, kidney, ureteral, bladder and urethral cancers, melanoma, osteosarcoma and chondrosarcoma — with individualized treatment plans.
Care for conditions where the immune system mistakenly attacks the body's own tissues.
Diagnosis and management of SLE and related systemic autoimmune conditions.
Treatment for rheumatoid arthritis, Sjögren's syndrome and inflammatory autoimmune joint disease.
Specialized care for scleroderma, mixed connective tissue disease and complex autoimmune presentations, including cellular immunotherapy approaches.
GOBROAD's flagship capabilities for conditions that resist conventional treatment.
A leading center for CAR-T cell immunotherapy, engineering a patient's own immune cells to target cancer.
Supported by 100+ transplant clean rooms and specialized cell-processing facilities for autologous and allogeneic transplant.
Next-generation genetic treatments delivered through an active clinical-research and cell-processing program.